(Q36258513)

13 August 2017

1 reference

title

Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

1 reference

Magnus Essand

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

44

1 reference

13 August 2017

6

1 reference

13 August 2017

610-627

1 reference

13 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Early prostate cancer: clinical decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A systematic overview of radiation therapy effects in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Diagnosis of local recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular cloning of human prostate specific antigen cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Primary structure of a human glandular kallikrein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular cloning of cDNA for human prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

GDEP, a new gene differentially expressed in normal prostate and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Synthetic DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Gene therapy clinical trials worldwide 1989-2004-an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Gene therapy of prostate cancer: current and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Viral therapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Expanded-capacity adenoviral vectors--the helper-dependent vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Novel prostate-specific promoter derived from PSA and PSMA enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Transcription-targeted gene therapy for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Molecular genetics of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Targeting gene therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

T-cell-receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Natural History of Early, Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510007477

10.1080/02841860510007477

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16165921